KLP Kapitalforvaltning’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$405K Hold
4,900
– – ﹤0.01% 1580
2026
Q2
$470K Hold
4,900
– – ﹤0.01% 1530
2026
Q1
$535K Buy
4,900
+300
+7% +$28.6K ﹤0.01% 1395
2025
Q4
$373K Buy
4,600
+200
+5% +$17.2K ﹤0.01% 1557
2025
Q3
$385K Hold
4,400
– – ﹤0.01% 1533
2025
Q2
$365K Buy
4,400
+600
+16% +$50.1K ﹤0.01% 1503
2025
Q1
$319K Sell
3,800
-5,000
-57% -$465K ﹤0.01% 1534
2024
Q4
$811K Buy
+8,800
New +$846K ﹤0.01% 1085

Other funds holding LMAT

KLP Kapitalforvaltning's LMAT Position: Q3 2026 in Review

KLP Kapitalforvaltning held its LeMaitre Vascular (LMAT) position steady in Q3 2026 at 4,900 shares worth $405K. The position accounts for ﹤0.01% of the portfolio, ranked #1580.

KLP Kapitalforvaltning first reported a position in LMAT in Q4 2024 and has held it in 8 quarters since. The position peaked at $811K in Q4 2024. 164 funds tracked by Wall St. Rank hold LMAT as of Q3 2026.

  • KLP Kapitalforvaltning held 4,900 shares of LeMaitre Vascular worth $405K as of Q3 2026.
  • KLP Kapitalforvaltning left its LeMaitre Vascular share count unchanged in Q3 2026.
  • LeMaitre Vascular made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q3 2026, its #1580 holding.
  • KLP Kapitalforvaltning first reported a position in LeMaitre Vascular in Q4 2024 and has held it in 8 quarters since.
  • KLP Kapitalforvaltning's LeMaitre Vascular position peaked at $811K in Q4 2024.
  • 164 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q3 2026, filed 10 Nov 2026.